Bachem renews supply contract with AstraZeneca
07-Feb-2017
- Switzerland
Dr. José de Chastonay, Chief Marketing Officer of the Bachem Group, commented: “This renewed long-term sales agreement emphasizes the high competitiveness of our products and services. For Bachem, it is also a clear validation of its market position as Pioneering Partner for Peptides. We are delighted about the renewed supply agreement as part of our very successful and long-standing partnership with AstraZeneca.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.